Detalles de la búsqueda
1.
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
N Engl J Med
; 388(26): 2444-2455, 2023 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379135
2.
Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
Dig Dis Sci
; 66(3): 925-927, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33063190
3.
The Influence of Bowel Preparation on ADC Measurements: Comparison between Conventional DWI and DWIBS Sequences.
Medicina (Kaunas)
; 55(7)2019 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31330916
4.
Current opinion on the management of iron deficiency anaemia in gastrointestinal diseases.
Eksp Klin Gastroenterol
; (10): 97-105, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25911939
5.
He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome.
Neurogastroenterol Motil
; : e14805, 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38651671
6.
Alterations in Polyunsaturated Fatty Acid Metabolism and Reduced Serum Eicosadienoic Acid Level in Ulcerative Colitis: Is There a Place for Metabolomic Fatty Acid Biomarkers in IBD?
Dig Dis Sci
; 63(9): 2480-2481, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29987625
7.
Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial.
J Crohns Colitis
; 16(11): 1714-1724, 2022 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35709376
8.
Comparison between Diffusion-Weighted Sequences with Selective and Non-Selective Fat Suppression in the Evaluation of Crohn's Disease Activity: Are They Equally Useful?
Diagnostics (Basel)
; 10(6)2020 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32471191
9.
Targeted Probiotics Against Bacterial-Fungal Biofilms: A New Concept Seems to Bring Us Closer to Microbiome-modulating Therapy for Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 29(11): e40-e41, 2023 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37672357
10.
Helicobacter pylori and Inflammatory Bowel Disease: An Unresolved Enigma.
Inflamm Bowel Dis
; 29(3): e5-e6, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36515237
11.
Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes.
Neurogastroenterol Motil
; 33(1): e14038, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33222317
12.
Gut Microbiota-Mediated Pleiotropic Effects of Fucose Can Improve Inflammatory Bowel Disease by Modulating Bile Acid Metabolism and Enhancing Propionate Production.
Inflamm Bowel Dis
; 27(2): e10-e11, 2021 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32879958
13.
Clinical Potential of Anti-inflammatory Effects of Faecalibacterium prausnitzii and Butyrate in Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 25(4): e40-e41, 2019 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30085080
14.
Gut Microbiota as a Host Defender and a Foe: The 2 Faces of Commensal Bacteroides thetaiotaomicron in Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 25(6): e71, 2019 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30561647
15.
Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome Is Another Key to the Pathogenesis of Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 25(12): e157-e158, 2019 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31560761
16.
Once versus three times daily dosing of oral budesonide for active Crohn's disease: a double-blind, double-dummy, randomised trial.
J Crohns Colitis
; 8(9): 970-80, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24534142
17.
A proposed treatment algorithm for mild to moderate ulcerative colitis-with an emphasis on budesonide foam and mucosal healing.
J Gastroenterol
; 53(6): 799-800, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29616331
18.
How to Increase the Butyrate-producing Capacity of the Gut Microbiome: Do IBD Patients Really Need Butyrate Replacement and Butyrogenic Therapy?
J Crohns Colitis
; 12(7): 881-882, 2018 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29528388
19.
Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.
J Gastrointestin Liver Dis
; 22(3): 333-6, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24078992
20.
Association of genetic variants with pancreatic cancer.
Cancer Genet Cytogenet
; 179(1): 76-8, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17981219